Case report demonstrates effective surgical management of maxillary mucormycosis in a diabetic patient, implying a novel approach may enhance outcomes.
Mucormycosis is a rapidly progressive, angioinvasive fungal infection that primarily affects immunocompromised patients, such as those with diabetes, organ transplantation, or hematological malignancies. Surgical debridement is essential in the management of this condition, but it traditionally requires extensive facial or nasal dissection. We report a case of a 58-year-old male diabetic patient with total maxillary necrosis due to mucormycosis, successfully managed using a modified midface degloving approach that avoids nasal dissection. The technique utilized an intra-oral route and a grasping bone method to remove necrotic bone along natural lines of separation created by the disease's pathophysiology. This approach not only provided a shorter operative time but also preserved the nasal anatomy, resulting in minimal morbidity and no external scarring. Additionally, the modified technique allowed for better access to the maxilla while minimizing damage to surrounding tissues. Our technique represents a safe, effective alternative for localized maxillary mucormycosis and warrants consideration in appropriate surgical cases
No takes yet. Share an insight, caveat, or question.
Qanah et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: